FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to carbamyloxy-compounds of the formula (I): wherein R1 is taken among group including alkyl, substituted alkyl, aryl, substituted aryl, heterocyclyl, substituted heterocyclyl, heteroaryl and substituted heteroaryl; R2 represents alkyl; R1 and R2 in common with nitrogen atom bound with R2. and SO2-- -group bound with R1 can form heterocyclic or substituted heterocyclic group; R3 represents hydrogen atom being when R2 doesn't form heterocyclic group with R1 then R2 and R3 in common with nitrogen atom bound with R2 and carbon atom bound with R3 can form heterocyclic or substituted heterocyclic group; R5 represents wherein is taken among group including O-Z- and O-Z-R12 wherein R8 and are taken independently among group including hydrogen atom, alkyl, substituted alkyl, heterocyclic and wherein R8 and are combined to form heterocycle or substituted heterocycle; R12 is taken among group including heterocycle and substituted heterocycle and Z represents C(O)-; Ar represents aryl, heteroaryl, substituted aryl or substituted heteroaryl; x is a whole number from 1 to 4; Q represents -C(X)NR7- wherein R7 represents hydrogen atom; X represents oxygen atom; and to its pharmaceutically acceptable salts; to compounds of the formula IA wherein radical R6, representing alkoxy-group, substituted alkoxy-group, cycloalkoxy-group or NH-adamantyl are taken instead hydroxyl group by C-end. Invention relates also to two pharmaceutical compositions showing ability to block or inhibit cellular adhesion and comprising compound of the formula (I) or compound of the formula IA as an active component and to method for binding VLA-4 in biological sample and to method for treatment of inflammatory states in mammalian patient. EFFECT: valuable biological and medicinal properties of compounds. 30 cl, 3 tbl, 348 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF REMYELINATING MEDICATION FOR STIMULATION OF NERVE CELLS IN CASE OF DEMYELINATING DISEASE | 2004 |
|
RU2412721C2 |
SUBSTITUTED DERIVATIVES OF 1-OXA-2,8-DIAZASPIRO[4,5]DEC-2-ENE, METHOD FOR PRODUCTION THEREOF AND DRUG HAVING ANALGESIC ACTION | 2002 |
|
RU2296128C2 |
NEW PIPERAZINE AMIDE DERIVATIVES | 2008 |
|
RU2454412C2 |
BENZOXAZINE DERIVATIVES AND THEIR APPLICATION | 2004 |
|
RU2354651C2 |
2,5-SUBSTITUTED TETRAHYDROISOQUINOLINE AND A PHARMACEUTICAL MODULATION COMPOSITION 5-НТ6 | 2004 |
|
RU2327689C2 |
METHOD OF OBTAINING INDOXYLIC OR THIOINDOXYLIC ESTERS OF AMINO ACIDS OR PEPTIDES | 0 |
|
SU1156595A3 |
IMIDAZOLIDINONE DERIVATIVES | 2008 |
|
RU2437882C2 |
VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
INDOLE DERIVATIVES SHOWING AFFINITY TO 5-HT RECEPTORS | 2002 |
|
RU2294932C2 |
Authors
Dates
2004-01-10—Published
1998-07-31—Filed